Callan JMB Inc. Common Stock (CJMB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Callan JMB Inc. Common Stock (CJMB) has a cash flow conversion efficiency ratio of -0.283x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-658.99K) by net assets ($2.33 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Callan JMB Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2022–2025)
This chart illustrates how Callan JMB Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Callan JMB Inc. Common Stock for a breakdown of total debt and financial obligations.
Callan JMB Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Callan JMB Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ENEFI Energiahatekonysagi Nyrt
BUD:ENEFI
|
-0.015x |
|
Tigi Ltd
TA:TIGI
|
0.002x |
|
Plurilock Security Inc
V:PLUR
|
0.048x |
|
AUXICO RESOURCES CANADA
F:A0H
|
N/A |
|
GB Group plc
LSE:GBG
|
0.047x |
|
Can Fite Biopharma Ltd ADR
NYSE MKT:CANF
|
-0.425x |
|
Westbond Enterprises Corp
V:WBE
|
0.025x |
|
Wira Global Solusi Tbk PT
JK:WGSH
|
0.021x |
Annual Cash Flow Conversion Efficiency for Callan JMB Inc. Common Stock (2022–2025)
The table below shows the annual cash flow conversion efficiency of Callan JMB Inc. Common Stock from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Callan JMB Inc. Common Stock.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $2.33 Million | $-4.55 Million | -1.953x | -1246.96% |
| 2024-12-31 | $3.17 Million | $540.35K | 0.170x | -78.59% |
| 2023-12-31 | $8.80 Million | $7.00 Million | 0.795x | +19.02% |
| 2022-12-31 | $14.01 Million | $9.36 Million | 0.668x | -- |
About Callan JMB Inc. Common Stock
Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, or… Read more